A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

José Miguel Rivera‐Caravaca; María Asunción Esteve‐Pastor; Francisco Marı́n; Mariano Valdés; Vicente Vicente; Vanessa Roldán; Professor Gregory Lip

doi:10.1016/j.mayocp.2018.01.028

Back

Shared by

Professor Gregory Lip

University of Liverpool

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

Article 2018 en

Authors

JR
José Miguel Rivera‐Caravaca
ME
María Asunción Esteve‐Pastor
FM
Francisco Marı́n

Related publications

Preprint2023

Quality of Anticoagulation and Predictors of Outcomes in Patients with Atrial Fibrillation Treated with Vitamin K Antagonists: A Real-World Evidence Analysis

Idelzuita Leandro Liporace, Gustavo Bernardes F. Oliveira, Lucas Bassolli, Nádia Marchiori Galassi, Fernanda Lopes, Andreia Dias Jeronimo, Professor Gregory Lip, Álvaro Avezum

Article2020

Outcomes in VKA‐treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real‐world’

Wern Yew Ding, José Miguel Rivera‐Caravaca, Alena Shantsila, Francisco Marı́n, Dhiraj Gupta, Vanessa Roldán, Professor Gregory Lip

Article2022

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists

Vanessa Roldán, Lorena Martínez-Montesinos, Raquel López‐Gálvez, Lucía García-Tomás, Professor Gregory Lip, José Miguel Rivera‐Caravaca, Francisco Marı́n

Article2017

Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Inmaculada Roldán‐Rabadán, Vanessa Roldán, Javier Muñiz, Paula Raña‐Míguez, Martín Ruiz Ortiz, Ángel Cequier, Vicente Bertoméu, Lina Badimón, Manuel Anguita, Professor Gregory Lip, Francisco Marı́n

Letter2019

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review

Steve Deitelzweig, Professor Gregory Lip

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

Discussion(0)

Related publications

Quality of Anticoagulation and Predictors of Outcomes in Patients with Atrial Fibrillation Treated with Vitamin K Antagonists: A Real-World Evidence Analysis

Outcomes in VKA‐treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real‐world’

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists

Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review